CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer – Final results

M. Sinn, Torsten Liersch, Hanno Riess, Klaus Gellert, P. Stübs, D. Waldschmidt, Frank Lammert, Georg Maschmeyer, Wolf O. Bechstein, Michael Bitzer, Claudio Denzlinger, Ralf‐Dieter Hofheinz, Udo Lindig, Michael Ghadimi, Axel Hinke, Jana K. Striefler, Uwe Pelzer, Sven Bischoff, Marcus Bahra, Helmut Oettle